Australia markets closed

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.9471-0.1429 (-13.11%)
As of 01:14PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.0900
Bid0.9508 x 900
Ask0.9550 x 2200
Day's range0.9255 - 1.0999
52-week range0.9255 - 8.8700
Avg. volume3,398,109
Market cap101.334M
Beta (5Y monthly)0.13
PE ratio (TTM)N/A
EPS (TTM)-2.4300
Earnings date30 Oct 2023 - 03 Nov 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est11.13
  • GlobeNewswire

    American College of Cardiology Program to Increase Cholesterol Screenings

    Quality Improvement and Education Program sponsored by Amgen, Esperion to improve adherence to guideline recommendations for managing LDL WASHINGTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- The American College of Cardiology, through a strategic collaboration with Amgen and Esperion, is launching a new quality improvement campaign, “Driving Urgency in LDL Screening,” to increase the rate of diagnostic LDL screening in patients without a prior cardiac event as well as those with known cardiovascular d

  • Zacks

    Why Is Esperion Therapeutics (ESPR) Down 10.6% Since Last Earnings Report?

    Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • GlobeNewswire

    Esperion to Participate in H.C. Wainwright 25th Annual Global Investment Conference

    ANN ARBOR, Mich., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced its participation in the H.C. Wainwright 25th Annual Global Investment Conference. Sheldon Koenig, President and Chief Executive Officer, will participate in a corporate presentation on Monday, September 11, 2023 at 3:00 PM ET. The Esperion management team will also host investor meetings that same day. To register for the live webcast, follow this link. A live audio webcast can be accessed on the investo